Drug · DIN 02493012
TRULANCE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since January 12, 2022; first marketed January 12, 2022.
- Drug Identification Number (DIN)
- 02493012
- Company (DIN owner)
- Bausch Health, Canada Inc.Laval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Plecanatide A06AX07
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| PLECANATIDE | 3 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- March 22, 2021: NOC 25494New Drug Submission (NDS) · Change in product ownership
- October 10, 2019: NOC 22769New Drug Submission (NDS)